Azadeh Nasrazadani, MD PHD
NPI 1770970766ActiveIndividual· Internal Medicine, Hematology & Oncology· Houston, TX
Internal Medicine, Hematology & Oncology (MD PHD) in Houston, Texas, trained at Paul L Foster School of Medicine, Texas Tech Univ (class of 2015). Their prescriptions cost Medicare Part D more than their services did: $701,797 for 204 claims, against $19,212 paid for services in 2024. Astrazeneca Uk Limited was the largest of 5 companies reporting payments in 2025, $10,607 in all, mostly consulting fees.
Overview
| NPI | 1770970766 |
|---|---|
| Status | Active |
| Entity type | Individual |
| Credential | MD PHD |
| Sole proprietor | No |
| NPI issued | Apr 17, 2015 |
| Last updated in NPPES | Mar 1, 2022 |
| Certified by provider | Mar 1, 2022 |
Specialties and licenses
| Taxonomy | Code | License | State |
|---|---|---|---|
| Internal Medicine, Hematology & Oncology Primary | 207RH0003X | T4014 | TX |
| Internal Medicine | 207R00000X | T4014 | TX |
| Internal Medicine | 207R00000X | MD470914 | PA |
| Internal Medicine, Hematology & Oncology | 207RH0003X | MD470914 | PA |
| Student in an Organized Health Care Education/Training Program | 390200000X | — | — |
Exclusion screening
| List | Result | Details |
|---|---|---|
| HHS-OIG LEIE · Nov 10, 2026 | No match | Checked by NPI and by name + state |
| North Carolina Medicaid · Nov 11, 2026 | No match | — |
| New York OMIG · Nov 11, 2026 | No match | — |
| Ohio Medicaid · Nov 11, 2026 | No match | — |
| Pennsylvania Medicheck · Nov 11, 2026 | No match | — |
| Washington HCA · Nov 11, 2026 | No match | — |
Official OIG search · How matching works ·Bulk check a roster
Medicare
| Enrollment (PECOS) | Enrolled Practitioner - Medical Oncology (PA); Practitioner - Hematology/Oncology (TX) |
|---|---|
| Accepts assignment | Yes (participating) |
Medicare services in 2024
| Medicare patients | 97 |
|---|---|
| Services billed | 205 across 11 procedure codes |
| Paid by Medicare | $19,212 |
Part D prescriptions in 2024
| Prescriptions (claims) | 204 · 307 30-day fills |
|---|---|
| Patients | 53 |
| Total drug cost | $701,797 |
| Generic share | 74% of claims |
Education and affiliations
| Medical school | Paul L Foster School of Medicine, Texas Tech Univ |
|---|---|
| Graduation year | 2015 |
| Medicare specialty | Hematology/Oncology |
| Telehealth | Offers telehealth |
Medical group
- Physicians Referral ServiceHouston, TX · 2,765 clinicians
Industry payments (Open Payments)
- 2025$10,607 · 7 payments from 5 companies
- 2024$769.98 · 8 payments from 5 companies
Top paying companies in 2025
| Company | Amount | Payments |
|---|---|---|
| Astrazeneca Uk Limited | $8,200 | 1 |
| Novartis Pharmaceuticals Corporation | $2,211 | 3 |
| Astrazeneca Pharmaceuticals LP | $90.91 | 1 |
| Stemline Therapeutics Inc. | $82.34 | 1 |
| Puma Biotechnology, Inc. | $23.41 | 1 |
What the 2025 payments were for
- Consulting Fee$10,263 · 2 payments
- Food and Beverage$344.73 · 5 payments
Receiving payments does not imply wrongdoing. What Open Payments covers ·original records
Other hematologist-oncologists in Houston
- 1013078294
- 1013956622
- 1023318284
- 1023343357
- 1023350105
- 1033478144
- 1053799304
- 1053845495
- 1073693339
- 1083707194
- 1104027549
- 1104089036
All 280 hematologist-oncologists in Houston · All hematologist-oncologists in Texas